Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity

@article{Carter2011CannabisIP,
  title={Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity},
  author={Gregory T Carter and Aaron M. Flanagan and Mitch Earleywine and Donald I. Abrams and Sunil Kumar Aggarwal and Lester Grinspoon},
  journal={American Journal of Hospice and Palliative Medicine{\textregistered}},
  year={2011},
  volume={28},
  pages={297 - 303}
}
Unlike hospice, long-term drug safety is an important issue in palliative medicine. Opioids may produce significant morbidity. Cannabis is a safer alternative with broad applicability for palliative care. Yet the Drug Enforcement Agency (DEA) classifies cannabis as Schedule I (dangerous, without medical uses). Dronabinol, a Schedule III prescription drug, is 100% tetrahydrocannabinol (THC), the most psychoactive ingredient in cannabis. Cannabis contains 20% THC or less but has other therapeutic… 
Opportunities for cannabis in supportive care in cancer
TLDR
There is a reasonable amount of evidence to consider cannabis for nausea and vomiting, loss of appetite, and pain as a supplement to first-line treatments, and promising evidence to treat chemotherapy-induced peripheral neuropathy, gastrointestinal distress, and sleep disorders, but the literature is thus far too limited to recommend cannabis for these symptoms.
Medical Cannabis and Utilization of Nonhospice Palliative Care Services: Complements and Alternatives at End of Life
TLDR
The results suggest that cannabis is largely an alternative to palliative care for terminal patients, and is a therapeutic complement used at higher levels of pain.
Prescribing cannabis for harm reduction
TLDR
Physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids, to reduce the morbidity and mortality rates associated with prescription pain medications.
Cannabis for symptom control #279.
TLDR
A number of countries have implemented pharmacy stocking and dispensing systems for herbal cannabis and/or oral cannabis extracts, available to patients by prescription, and providers must be familiar with their own state’s laws and regulatory climate around authorizing cannabis use.
Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population
TLDR
Early patterns of tetrahydrocannabinol and cannabidiol use in Florida following passage of the state’s first medical marijuana law are described to describe the perceived benefits, side effects, and beliefs expressed by patients in a single outpatient academic palliative medicine practice.
Efficacy, tolerability and safety of cannabis-based medicines for cancer pain
TLDR
Very low quality evidence suggests that oromucosal nabiximols and THC have no effect on pain, sleep problems and opioid consumption in patients with cancer pain with insufficient pain relief from opioids.
The argument for medical marijuana for the treatment of chronic pain.
TLDR
This patient has legitimate pain and still deserves treatment despite being at high risk for substance abuse, and medicinal cannabis can be considered a legitimate next treatment step, much preferred to a prescription for opioids.
[Marijuana for medical purposes--public health perspective].
TLDR
Marijuana has a range of adverse health effects, particularly relating to young people because of higher risk for psychosis, traffic accidents, and cognitive impairment, and there are more considerations about its ability to treat a number of diseases.
A Scoping Review of the Use of Cannabis and Its Extracts as Potential Harm Reduction Strategies: Insights from Preclinical and Clinical Research
TLDR
Across 33 countries, 57 articles were identified demonstrating that cannabinoids enhance opioid analgesia while reducing tolerance and dependence, and interrupt dependence on cocaine, alcohol, and nicotine, and can be vaporized or eaten to reduce harms associated with smoking.
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature
TLDR
The most robust evidence suggests that medical cannabis may be effective in the treatment of chemotherapy-induced nausea and vomiting, seizure disorders, MS-related spasticity, and pain (excluding diabetic neuropathy).
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 111 REFERENCES
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
TLDR
Smoked cannabis was generally well tolerated and effective when added to concomitant analgesic therapy in patients with medically refractory pain due to HIV DSPN.
The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research.
TLDR
The authors present case histories indicating that a number of patients find cannabis (marihuana) useful in the treatment of their bipolar disorder, and describe the use of cannabis as a supplement to lithium or for relief of lithium's side effects.
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain.
Deaths With Transdermal Fentanyl Patches
  • M. Jumbelic
  • Medicine
    The American journal of forensic medicine and pathology
  • 2010
TLDR
Fentanyl is a potent Schedule II narcotic analgesic recommended for use in the management of unremitting pain not controlled by morphine or other opiate/opioid drugs and a rise in the popularity of this drug evidenced by increased deaths among drug abusers and more prescriptions written.
Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base.
Medicinal cannabis: rational guidelines for dosing.
TLDR
This paper will review the known chemistry and pharmacology of cannabis and, on that basis, discuss rational guidelines for dosing.
Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)
TLDR
The criteria for selecting analgesics for pain treatment in the elderly include, but are not limited to, overall efficacy, overall side‐effect profile, onset of action, drug interactions, abuse potential, and practical issues, such as cost and availability of the drug, as well as the severity and type of pain.
Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.
TLDR
Data indicate that males and females access MC at approximately the same rate, with similar median authorization times, and major treatment access and delivery barriers remain.
Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.
TLDR
The superiority of the anti-emetic efficacy of cannabinoids was demonstrated through meta-analysis and the adverse effects were more intense and occurred more often among patients who used cannabinoids.
Cannabis in painful HIV-associated sensory neuropathy
TLDR
Smoked cannabis was well tolerated and effectively relieved chronic neuropathic pain from HIV-associated sensory neuropathy and the findings are comparable to oral drugs used for chronic Neuropathic pain.
...
1
2
3
4
5
...